Bio-Rad Laboratories | BIO - Operating Expenses

Stock Price
298.98
Daily Change
1.55 0.52%
Monthly
-7.25%
Yearly
-13.40%
Q1 Forecast
284.65

Bio-Rad Laboratories reported $6.74B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Agilent USD 1.42B 57M Sep/2025
Becton, Dickinson and Co. USD 5.07B 535M Sep/2025
Bio Techne USD 238.9M 101.93M Sep/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Bruker USD 776.6M 8.9M Sep/2025
Charles River Laboratories USD 3.41B 2.51B Sep/2025
Danaher USD 5.34B 45.74B Dec/2025
Exact Sciences USD 875.74M 62.51M Sep/2025
General Electric Aerospace USD 10.94B 7.87B Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 834M 20M Sep/2025
IQVIA Holdings USD 6.16B 2.7B Sep/2025
Laboratory Of America USD 3.17B 101.7M Sep/2025
Merck USD 10.72B 1.28B Sep/2025
Mettler Toledo International USD 735.5M 17.99M Sep/2025
Myriad Genetics USD 229M 3.4M Sep/2025
Quest Diagnostics USD 7.26B 4.94B Sep/2025
Repligen USD 176.13M 279K Sep/2025
Revvity USD 600.61M 12.7M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Siemens EUR 18.86B 2.24B Sep/2025
Standard Biotools USD 43.02M 2.44M Sep/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Tosoh JPY 225.35B 3.7B Sep/2025
Waters USD 2.33B 1.75B Sep/2025